ArticleFrontiers in neuroergonomics2021
European NCAP Program Developments to Address Driver Distraction, Drowsiness and Sudden Sickness.
Article in Frontiers in neuroergonomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 22 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Driver distraction and drowsiness remain significant contributors to death and serious injury on our roads and are long standing issues in road safety strategies around the world. With developments in automotive technology, including driver monitoring, there are now more options available for automotive manufactures to mitigate risks associated with driver state. Such developments in Occupant Status Monitoring (OSM) are being incorporated into the European New Car Assessment Programme (Euro NCAP) Safety Assist protocols. The requirements for OSM technologies are discussed along two dimensions: detection difficulty and behavioral complexity. More capable solutions will be able to provide higher levels of system availability, being the proportion of time a system could provide protection to the driver, and will be able to capture a greater proportion of complex real-word driver behavior. The testing approach could initially propose testing using both a dossier of evidence provided by the Original Equipment Manufacturer (OEM) alongside selected use of track testing. More capable systems will not rely only on warning strategies but will also include intervention strategies when a driver is not attentive. The roadmap for future OSM protocol development could consider a range of known and emerging safety risks including driving while intoxicated by alcohol or drugs, cognitive distraction, and the driver engagement requirements for supervision and take-over performance with assisted and automated driving features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.